Cardiac CT Angiography for Atrial Fibrillation and Flutter
(LA CLOTTED Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to manage atrial fibrillation or atrial flutter (irregular heartbeats) in the emergency department using cardiac computed tomography angiography (CCT). The goal is to determine if this scan can help doctors make faster decisions, avoid hospital admissions, and improve quality of life compared to current methods. Participants will either receive the CCT scan or follow the usual treatment approach to compare outcomes. The trial seeks individuals with ongoing symptoms of atrial fibrillation who need a heart scan before undergoing a procedure to restore normal heart rhythm. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could transform emergency heart care.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that cardiac computed tomography angiography is safe for patients with atrial fibrillation or flutter?
Previous studies have shown that cardiac computed tomography angiography (CCT) is a safe and well-tolerated procedure. Research indicates that CCT, a non-invasive method, carries fewer risks than some other imaging techniques. For instance, CCT effectively detects heart problems, making it a reliable choice for patients. It can identify issues without causing harm.
While every medical procedure carries some risk, evidence shows that serious problems with CCT are rare and usually minor. This makes it a promising option for heart imaging, particularly for detecting blood clots before treatments like cardioversion, which helps restore a regular heart rhythm.12345Why are researchers excited about this trial?
Researchers are excited about using cardiac computed tomography angiography (CCT) for atrial fibrillation and flutter because it offers a unique way to assess the presence of left atrial thrombus quickly and non-invasively. Unlike the standard of care, which might involve weeks of anticoagulation before cardioversion or complex decision-making involving transesophageal echocardiograms, CCT provides rapid imaging results that can immediately inform treatment decisions. This fast evaluation can allow for quicker cardioversion if no thrombus is present, potentially reducing the time patients spend in irregular heart rhythms and enhancing their overall care experience.
What evidence suggests that cardiac computed tomography angiography is effective for atrial fibrillation and flutter?
Research has shown that cardiac computed tomography angiography (CCT), which participants in this trial may receive, is a promising tool for detecting blood clots in the heart. One study found that CCT effectively detects clots in the left atrial appendage, a common location for clots in individuals with atrial fibrillation or flutter. This imaging method can effectively rule out clots, allowing doctors to safely perform cardioversion, a procedure to reset the heart's rhythm. By using CCT, doctors may lower the risk of strokes and improve patient outcomes compared to traditional methods. Overall, CCT offers a non-invasive way to assess heart health and guide treatment decisions.12367
Who Is on the Research Team?
Benjamin Chow, MD PhD FRCPC FACC FESC FA
Principal Investigator
Ottawa Heart Institute Research Corporation
Mehrdad Golian, MD MSC FRCPC
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
This trial is for patients with symptomatic atrial fibrillation or flutter needing to check for blood clots before cardioversion. It's not specified who can't join, but typically those with certain health risks or conditions that conflict with the study requirements would be excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo CCT-facilitated cardioversion or standard care management in the emergency department
Follow-up
Participants complete quality of life questionnaires and are monitored for safety and effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- Cardiac computed tomography angiography
Trial Overview
The study compares two approaches: using cardiac computed tomography angiography (CCT) in the emergency department versus standard care to prepare for heart rhythm normalization (cardioversion). The aim is to see if CCT leads to fewer hospital stays and better quality of life.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Patients in this arm will undergo cardiac computed tomography angiography (CCT) to evaluate for a left atrial/left atrial appendage (LA) thrombus. If the CCT shows no LA thrombus then the emergency department physician will be able to perform electrical and/or chemical cardioversion at their discretion. If the CCT shows a LA thrombus then cardioversion will be contraindicated and further management will be at the discretion of the treating physician.
Patients in the control arm will be treated according to current standard of care as determined by the primary treating emergency department physician and may vary by institution and physician. Treatment in the standard of care group may include a rate control strategy with or without a planned cardioversion after 3 weeks of anticoagulation, deferring management for outpatient evaluation, request for TEE-facilitated cardioversion in the ED, or specialist consultation for further management or admission to hospital.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor
Citations
Abstract 4364910: Trends and Stroke Outcomes in Left ...
However, cardiac computed tomography angiography (CCTA) has emerged as a non-invasive, lower-risk alternative with high sensitivity and ...
CT coronary angiography in atrial fibrillation
Diagnostic performance of 320-detector CT coronary angiography in patients with atrial fibrillation: preliminary results. Eur Radiol 2011; 21: 936–43. doi ...
Five-Year Outcomes After Coronary Computed ...
Five-year all-cause mortality were 2.8% versus 4.2%, 5.5% versus 8.8%, and 6.7% versus 8.5%, all p <0.001. In conclusion, the 5-year MI or ...
Effectiveness of integrating delayed computed tomography ...
Computed tomography angiography (CTA) can identify and rule out left atrial appendage (LAA) thrombus when delayed imaging is also performed.
NCT07002450 | Left Atrial Imaging Prior to Cardioversion: ...
This study is a multicenter randomized trial that will evaluate the effectiveness of using CCT facilitated cardioversion in the ED compared to current standard ...
Cardiac Computed Tomography (CT), Coronary CT ...
This Clinical Policy Bulletin addresses cardiac computed tomography (CT), coronary CT angiography, calcium scoring and CT fractional flow reserve.
SCCT 2021 Expert Consensus Document on Coronary ...
The identification of both obstructive and non-obstructive CAD is associated with worse prognosis in patients undergoing CTA. The COronary CT ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.